Biological medicines for asthma

No definition available.

Endpoint definition

↥
FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC R03DX05|R03DX08|R03DX09|R03DX10|D11AH05
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_ASTMA_BIOL

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 33 22 11
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 49.40 50.29 47.62

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

↥

Index endpoint: RX_ASTMA_BIOL – Biological medicines for asthma
GWS hits:

Survival analyses between endpoints

↥

Plot

before Biological medicines for asthma
after Biological medicines for asthma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Biological medicines for asthma

↥